Early Check Study to Use Genome Sequencing to Dramatically Expand Voluntary Screening Offered for NC Newborns
This RTI/UNC-Chapel Hill collaboration will be the first US study offering genome sequencing and genetic risk scores for type 1 diabetes statewide. UNC School of Medicine leads are Cynthia Powell, MD and Jennifer Law, MD in Pediatrics. Early Check, a groundbreaking research study that provides free health tests to newborns up to four weeks old in North Carolina, will begin offering genome sequencing to screen for hundreds of childhood-onset genetic conditions and assess a newborn’s risk of developing type 1 diabetes in their lifetime. Enrollment for the expanded study is expected to begin Thursday, Sept. 28.